Moomoo AI 已提取核心信息
Joseph Vittiglio, the Chief Business & Legal Officer of bluebird bio, Inc. (BLUE), was involved in a transaction with the company's stock on March 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Vittiglio after the transaction. The absence of these details leaves the impact of the transaction on Vittiglio's holdings and the company's stock undetermined.
Joseph Vittiglio, the Chief Business & Legal Officer of bluebird bio, Inc. (BLUE), was involved in a transaction with the company's stock on March 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Vittiglio after the transaction. The absence of these details leaves the impact of the transaction on Vittiglio's holdings and the company's stock undetermined.
蓝鸟生物公司（BLUE）的首席商务和法律官约瑟夫·维蒂格里奥于2024年3月1日参与了与该公司股票的交易。公告中未披露该交易的具体细节，包括股票数量、股票性质、交易价格和股票总价值。该报告也没有提供有关Vittiglio在交易后持有的股票数量的信息。这些细节的缺乏使该交易对维蒂格里奥持股和公司股票的影响尚不确定。
蓝鸟生物公司（BLUE）的首席商务和法律官约瑟夫·维蒂格里奥于2024年3月1日参与了与该公司股票的交易。公告中未披露该交易的具体细节，包括股票数量、股票性质、交易价格和股票总价值。该报告也没有提供有关Vittiglio在交易后持有的股票数量的信息。这些细节的缺乏使该交易对维蒂格里奥持股和公司股票的影响尚不确定。
有用
没用